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Abstract 
Background 
The role of laparoscopy in the treatment of extraperitoneal rectal cancer is still controversial. The 
aim of the study was to evaluate differences in safety of laparoscopic rectal resection for 
extraperitoneal cancer, compared with open surgery. 
Materials and methods 
A systematic review from 2000 to July 2012 was performed searching the MEDLINE and 
EMBASE databases (PROSPERO registration number CRD42012002406). We included 
randomized and prospective controlled clinical studies comparing laparoscopic and open resection 
for rectal cancer. Primary endpoints were 30-day mortality and morbidity. Then a meta-analysis 
was conducted by a fixed-effect model, performing a sensitivity analysis by a random-effect model. 
Relative risk (RR) was used as an indicator of treatment effect. 
Results 
Eleven studies, representing 1684 patients, met the inclusion criteria: four were randomized for a 
total of 814 patients. Mortality was observed in 1.2% of patients in the laparoscopic group and in 
2.3% of patients in the open group, with an RR of 0.56 (95% CI 0.19–1.64, p = 0.287). The overall 
incidence of short-term complications was lower in the laparoscopic group (31.5%) compared to the 
open group (38.2%), with an RR of 0.83 (95% CI 0.73–0.94, p = 0.004). Surgical complications, 
wound complications, blood loss and the need for blood transfusion, time for bowel movement 
recovery, food intake recovery, and hospital stay were significantly lower or less frequent in the 
laparoscopic group. The incidence of intra-operative injuries, anastomotic leakages, and surgical re-
interventions was similar in the two groups. Only operative time was in favour of the open group. 
Conclusions 
Based on the evidence of both randomized and prospective controlled series, mortality was lower 
after laparoscopy although not significantly so, while the short-term morbidity RR, including 
subgroup analysis, was significantly lower after laparoscopy for extraperitoneal rectal cancer 
compared to open surgery. 
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Introduction 
Laparoscopy for colon cancer, first described by Jacobs et al. in 1991,1 aroused interest after the 
publication of the randomized trial by Lacy et al. in 20022 and obtained acceptance after the 
publication of the three trials COST, COLOR and CLASICC.3–5 With the exception of the 
CLASICC trial, patients with rectal cancer were not included in these studies. 
Excellence of surgical technique is of particular relevance in the treatment of rectal cancer. Routine 
excision of the intact mesorectum during resection of cancers of the middle and lower rectum has 
resulted in a consistent reduction of local recurrences6 and in an increase in long-term survival 
rates.7 
While awaiting long-term oncological results, different studies have reported on postoperative and 
short-term results, advocating similar advantages of minimally invasive treatment as for many other 
procedures, including less pain, shorter postoperative ileus, earlier return to oral intake, shorter 
hospital stay, and lower blood loss.8,9 As the analysis of short-term benefits of laparoscopy should 
be in some way a prerequisite for the analysis of long-term results, with the present study we 
intended to evaluate in a meta-analysis whether there are clinically relevant short-term advantages 
of either laparoscopy or laparotomy for surgical treatment of extraperitoneal rectal cancer in the 
published literature. While the assessment of laparoscopic advantages in rectal cancer treatment has 
been the topic of other systematic reviews and meta-analyses in the past, this is the first meta-
analysis that specifically focuses on extraperitoneal rectal cancer. 
Materials and methods 
The methods for the analysis and generation of inclusion criteria were based on the 
recommendations of the Preferred Reporting Items for Systematic reviews and Meta-Analysis 
(PRISMA) Statement.10 According to population, interventions, comparators, outcome measures, 
and setting (PICOS) criteria, patients were included if affected with extraperitoneal rectal cancer for 
which laparoscopic or laparotomic treatment was indicated. The study methods were documented 
Prospero, an international prospective register of systematic reviews (registration number 
CRD42012002406). 
Studies 
Only randomized controlled trials (RCTs) or prospective controlled clinical trials (noRCTs) were 
considered for this analysis, as suggested by the MOOSE group.11 Studies were excluded if the 
study population included colon cancers or intraperitoneal rectal cancers, unless the data were 
presented separately. When multiple studies from the same institution were identified, the most 
recent or the most informative was selected. All and only full-text papers in English were 
considered. 
Participants 
This meta-analysis compares laparoscopic and laparotomic resection for extraperitoneal rectal 
cancer with regard to possible benefits of laparoscopy or laparotomy in the short-term postoperative 
period, defined as up to 30 days after surgery. 
Intervention 
All surgical procedures involving resection of rectal cancers defined either as of the mid and low 
rectum, or extraperitoneal or lower than 12 cm from the anal verge, were considered, including 
partial or total mesorectal excision with mechanical of hand-sutured anastomosis, Hartmann 
procedures, and abdominoperineal resection. Type of interventions performed were noted in order 
to analyse separately those involving and those not involving a bowel anastomosis. For the 
laparoscopic group, any rectal resection performed by means of a mini-invasive approach (i.e. in a 
space generated by an insufflated pneumoperitoneum with operative field visualization obtained by 
a videolaparoscope and performed only with laparoscopic trocars) was included, while all 
procedures described as ‘open’ or ‘conventional’ and performed by means of an abdominal 
laparotomic incision were considered as open surgery. 
Outcome measures 
Primary endpoints were overall mortality and morbidity at 30 days after surgery. Intraoperative and 
early (<30 days) postoperative complications directly related to surgery, and early (<30 days) 
postoperative medical complications were the subject of different sensitivity analyses. Anastomotic 
leakage, bleeding and blood loss, wound infection and/or wound dehiscence, pelvic and/or 
abdominal abscesses, and bowel and/or vascular and/or urological injuries were classified as 
surgical complications. Paralitic ileum and/or non-surgical bowel obstruction, respiratory events, 
cardiovascular events, deep venous thrombosis and/or pulmonary embolism, urinary infection, 
urinary retention, non-surgical infections, or sepsis were classified as medical complications. 
The secondary outcome measures were incidence of anastomotic leakage, abscesses, blood loss, 
time to first bowel movement, time for intake recovery, need for transfusion, length of hospital stay, 
wound infections, internal organ injuries, need for re-intervention, and operative time. 
Results 
Study selection 
The search retrieved 5017 studies. Figure 1 illustrates the PRISMA flowchart for study inclusion 
and exclusion criteria.  
Characteristics of included studies 
The characteristics of the 11 studies meeting the inclusion criteria are summarized in Table 1.12–22 
All 11 studies were reported as full papers and included a total of 1684 patients. Four studies were 
RCTs for a total of 814 patients and seven studies were noRCTs for a total of 870 patients.  
 
 
Risk of bias of included studies 
Assessment of quality according to the Cochrane Collaboration’s tool for assessing risk of bias for 
RCTs and to the Newcastle-Ottawa Scale for prospective noRCTs are represented in Tables 
Tables44 and and5,5, respectively.  
Quality analysis 
Figure 2 shows the potential sources of heterogeneity within all studies by a L’Abbé plot on 
mortality outcome. Since in most of the analyses I2 was <50%, the fixed-effects and random-effects 
model results can be considered comparable.  
Primary outcomes 
The meta-analyses of the two primary outcomes investigated mortality and overall complications. 
For the first primary outcome, the raw incidence of mortality, as reported in five studies, was lower 
in the laparoscopic group (1.2%) compared to the open group (2.3%). The overall relative risk (RR) 
was 0.56 (95% CI 0.19–1.64, p = 0.287), showing no heterogeneity (I2 = 0%) and no differences 
between RCTs vs. noRCTs subgroups (RR 0.75 vs. 0.41, p = 0.590; Figure 3). Performing a 
cumulative meta-analysis with these five studies (two RCTs and three noRCTs), adding one study 
at a time by publication date, the RR progressively raised from 0.33 to 0.59; performing an 
influential meta-analysis, by omitting one study in turn, the RR ranged from 0.50 to 0.60 over the 
whole time frame.  
 
For the second primary outcome, the incidence of overall 30-day morbidity, as reported in 10 
studies, was significantly lower in the laparoscopic (31.5%) compared to the open group (38.2%). 
The overall RR was 0.83 (95% CI 0.73–0.94, p = 0.004), showing very low heterogeneity 
(I2 = 8.2%) and no statistically significant differences between RCT vs. noRCT trials (RR 0.84 vs. 
0.83, p = 0.934; Figure 4). Performing a cumulative meta-analysis with these 10 studies (four RCTs 
and six noRCTs), the RR varied from 0.96 to 0.70, being almost constant in the period 2007–2011. 
In the influential meta-analysis, the RR resulted almost stable over the whole publication period, 
ranging between 0.81 and 0.86.  
Secondary outcomes 
As secondary outcomes, the meta-analysis investigated medical and surgical complications in 
detail, i.e. patients with medical and/or surgical complications, surgical duration, mean blood loss, 
incidence of intra-operative injuries, bowel movement recovery, food intake recovery, blood 
transfusions, incidence of abscesses, incidence of wound complications, incidence of anastomotic 
leakages, incidence of re-intervention, and length of hospital stay. 
Surgical complications, as reported in 10 studies, were significantly less frequent in the 
laparoscopic vs. the open group (13.5 vs. 17.5%); the overall RR was 0.78 (95% CI 0.62–0.97, 
p = 0.027; Figure 5), with no differences between RCT vs. noRCT subgroups (RR 0.65 vs. 0.86, 
p = 0.247). 
 
Patients with medical complications, as reported in nine studies, were 18.5% in the laparoscopic 
group and 22.0% in the open surgery arm; the overall RR was 0.85 (95% CI 0.70–1.04, p = 0.114; 
Figure 6), again with no differences between RCTs and noRCTs (RR 0.95 vs. 0.73, p = 0.201).  
 
All but one study12 provided conversion to open surgery rate. Overall, 61 laparoscopic cases out of 
740 were converted to laparotomy (8.2%): 4.7% (15/322) in the RCT studies and 11.0% (46/418) in 
the noRCT studies. Conversion rates ranged between 1.2%15 and 9.8%17 in the RCT studies, and 
between 0%20 and 18.4%13 in the noRCT studies. In the RCT studies, reported conversion rates 
showed a time trend, which was not apparent in the noRCTs (Table 1). 
The weighted mean operative time, as reported in 10 studies, was significantly longer for 
laparoscopic surgery (216 and 179 minutes, respectively); the overall mean difference (MD) was 
36.4 minutes (95% CI 25.1–47.6, p < 0.001; Figure 7), with no notable MDs between RCTs and 
noRCTs (32.4 vs. 39.4 minutes, p = 0.557), but with considerable heterogeneity (I2 83.4%).  
 
The weighted mean blood loss, as reported in eight studies, was almost halved in the laparoscopic 
group (226 vs. 412 ml); the overall MD was −138 ml (95% CI −195 to −81, p < 0.001; Figure 8), 
with borderline subgroup differences (MD −83 vs. −181, p = 0.056) and consistent heterogeneity (I2 
83.4%).  
 
The overall incidence of intra-operative injuries, as reported in six studies, was 1.4% in both 
laparoscopic and open surgery patients; the overall RR was 1.10 (95% CI 0.41–2.91, p = 0.851; 
Figure 9), with no differences between RCTs and noRCTs (RR 1.65 vs. 0.74 p = 0.428).  
 
The weighted mean time for bowel movement recovery, as reported in six studies, was significantly 
shorter in the laparoscopic group (3.5 vs. 4.7 days); the overall MD was −1.3 days (95% CI −1.8 to 
−0.9, p < 0.001; Figure 10), with no significant MD between RCTs and noRCTs (MD −1.2 vs. −1.3, 
p = 0.827) but in the presence of extreme heterogeneity (I2 83.9%).  
The weighted mean food intake recovery, as reported in nine studies, occurred after 4.0 days in the 
laparoscopic group and 4.8 days in the open surgery group, significantly favouring the former; the 
overall MD was −0.9 days (95% CI −1.4 to −0.4, p < 0.001; Figure 11), showing a significant MD 
between RCTs and noRCTs (MD −0.3 vs. −1.0, p = 0.031) and extreme heterogeneity (I2 75.9%).  
 
The percentage of laparoscopic patients requiring blood transfusions, as reported in three studies, 
was significantly lower than that for open surgery patients (4.5 vs. 7.0%); the overall RR was 0.55 
(95% CI 0.31–0.98, p = 0.041; Figure 12), in the absence of subgroup differences (RR 0.33 vs. 0.57, 
p = 0.749).  
 
 
Abscesses, as reported in seven studies, were observed in 1.8% of patients in the laparoscopic group 
and 1.9% of patients in the open group; the overall RR was 1.08 (95% CI 0.50–2.36, p = 0.837; 
Figure 13), showing no subgroup differences (RR 1.00 vs. 1.14, p = 0.871).  
 
On the other hand, wound complications, as reported in 10 studies, were described for 6.9% 
laparoscopic and 11.1% open patients; the overall RR was 0.63 (95% CI 0.46–0.86, p = 0.004; 
Figure 14), with no subgroup differences (RR 0.57 vs. 0.66, p = 0.646).  
 
Anastomotic leakages, as reported in eight studies, occurred in 6.9% of laparoscopic patients and 
6.3% of open patients. The overall RR was 1.05 (95% CI 0.68–1.61, p = 0.833; Figure 15), with no 
differences between RCTs and noRCTs (RR 0.66 vs. 1.26, p = 0.192).  
 
Patients who needed surgical re-intervention within the first 30 postoperative days, as reported in 
six studies, were 5.3% in the laparoscopic group and 6.9% in the open group; the overall RR was 
0.75 (95% CI 0.47–1.19, p = 0.217; Figure 16), again with no subgroup differences (RR 0.71 vs. 
0.78, p = 0.838).  
 
The weighted mean duration for hospital stay, as reported in 10 studies, was clearly shorter in the 
laparoscopy surgery patients (10.2 vs. 12.4 days); the overall MD was −2.2 days (95% CI −3.7 to 
−0.7, p = 0.005; Figure 17), with no differences in the subgroup analysis (MD −2.7 vs. −1.9, 
p = 0.651), but with extreme heterogeneity (I2 79.8%).  
 
Discussion 
According to European registries, the prevalence of rectal cancer exceeds 50 cases per 100,000 
(women and men). It accounts for almost 40% of all colorectal cancer cases23,24 representing one of 
the leading causes of cancer mortality, in which local recurrence of rectal cancer plays a major role. 
For mid and low rectal cancers, total mesorectal excision remains the main-stay of therapy. The 
feasibility of laparoscopic resection of rectal cancer has been demonstrated for many years when 
performed by expert laparoscopists, but while the laparoscopic approach in colon cancer has been 
proved to be safe and feasible with equivalent long-term oncological outcome compared to open 
surgery,3–5 the safety of laparoscopic surgery for rectal cancer is still debated both for short-term 
and long-term outcomes. 
While mid and long-term oncological results are awaited, the present study aimed to assess by 
means of a systematic review and meta-analysis, the short-term safety of laparoscopic resection for 
extraperitoneal rectal cancer. Different meta-analyses have compared laparoscopic and open 
techniques for colorectal25–29 and later for rectal cancers,30–33 although only including intra-
peritoneal lesions. This is in fact the first meta-analysis that focuses only on extra-peritoneal rectal 
cancers. In this restricted field of mid and low rectal surgery, the issue of increased technical 
challenges arises. 
Since 2000, 11 studies12–22 have been published comparing laparoscopic and open rectal resection in 
terms of safety. We restricted the beginning of the analysis to the year 2000 in order to include 
studies performed with a relative experience of the technique, as it had already been proposed 
around 8 years previously. This was considered important in order to obtain results as homogeneous 
as possible. Although a meta-analysis of only RCT studies might be considered preferable, the risk 
of bias analysis and the heterogeneity test showed that extending the inclusion criteria to 
prospective non-randomized matched series would have allowed a consistent level of evidence to be 
maintained. The heterogeneity of results was null or kept within a reasonable range for most of the 
outcomes considered, in particular for the two primary ones, despite the fact that some of the study 
samples included in this analysis were relatively small and that none of the studies included had 
made an estimate of what sample size was needed to detect any differences between laparoscopic 
and open surgery based on a well-defined primary outcome. The sensitivity analyses showed that no 
study played an influential role on RR in the whole time period. Where data were available, stage of 
cancer disease, neoadjuvant chemoradiotherapy, protective ileostomy rates, and type of surgery 
(partial or total mesorectal excision or abdominoperineal resection) were all variables considered in 
the comparative analysis between open and laparoscopic groups. The quality assessment for both 
RCT and noRCT studies as measured by the Cochrane Collaboration’s tool for assessing risk of 
bias and the Newcastle-Ottawa scale was interestingly high. 
An important aspect of the present analysis is that all studies were performed at specialized centres 
by highly experienced surgeons, and that patients were rigorously selected, particularly those staged 
T4 by TNM stage who were excluded in all but two studies. 
In the light of the methodology of the present study, the results obtained appear highly significant. 
The main result of the meta-analysis was that the incidence of overall morbidity at 30 days showed 
a significant reduction in the laparoscopic group compared to open surgery with an RR of 0.83. 
Furthermore the mortality analysis showed a trend in favour of laparoscopy, although it may not 
have reached statistical significance due to the relative rarity of the event. The subgroup analysis 
confirmed that surgical complications are also significantly lower in the laparoscopic group, while 
medical complications showed a consistent trend in favour of laparoscopy although with no 
statistical significance. Apart from the operative time, which was significantly in favour of open 
surgery, the analysis of all the studies included showed a clear advantage for laparoscopy also in the 
specific analysis of other comparative outcomes. Blood loss, time for bowel movement recovery, 
food intake recovery, need for blood transfusion, wound complications, and duration of hospital 
stay were all significantly in favour of laparoscopy, while no significant difference was observed in 
terms of anastomotic leakages, intra-operative injuries, abscess formation, and the need for surgical 
re-intervention at 30 days. 
While most of the above-mentioned results were expected, as they confirmed the well-known 
advantages of minimally invasive techniques shown in other surgical procedures, the absence of any 
difference in anastomotic leakage rates was particularly striking. In fact, in the past few years, 
concern has been expressed about the increase in anastomotic leakage risk associated with 
laparoscopy. This risk was accounted for by the difficult access of laparoscopic linear staplers to the 
distal rectum in a narrow pelvis, the oblique transection from right to left or from anterior to 
posterior (depending on the position of the trocar used for the stapler), and the difficulty of cephalad 
traction on the rectum. This had led the EAES Consensus panel of experts to affirm that ‘a 
cautionary note should be commented in relation to the anastomotic leak rate, in relation to the 
difficulty observed for low rectal transection in the obese or in those with a narrow pelvis space’.34 
In recent years, the advent of new technologies, such as the ultrasonic scalpel and articulated 
stapler, and the increase in surgical experience has resulted in a progressive optimization of the 
technique which has recently led to an equivalence in leakage rates and a lower incidence of 
surgical complications with the laparoscopic approach. 
Only the lack of sufficient data referring to sexual and urinary dysfunctions, postoperative quality 
of life and R0 achievement, and sphincter preservation rates prevented further analyses which 
would also undoubtedly have proved interesting from being performed. 
The results obtained should in any case be interpreted with caution as the present analysis shows 
certain limitations. Despite the high quality assessment for low risk of bias, most of the studies did 
not have short-term complications as primary outcome, while others lacked important data with 
regard to secondary outcomes. 
In spite of the above-mentioned limitations, it can be concluded that, based on the evidence of both 
randomized and prospective matched series, laparoscopic resection appears to have clinically 
measurable short-term advantages in patients with primary resectable extraperitoneal rectal cancer. 
Although technically demanding, laparoscopic rectal resection for extraperitoneal cancer in selected 
patients can be considered safe and guarantees faster recovery; it is therefore to be recommended 
under optimal conditions. 
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